Anthony Wilkinson

Has grant

Professor

University of York
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Anthony Wilkinson is a faculty member at the University of York, UK. His research encompasses various areas including microbial pathogenesis, structural biology, and transporter proteins. Recent publications highlight his work on the mechanisms of itaconate utilization in Pseudomonas aeruginosa, as well as studies on deubiquitinases and peptide transport systems. Professor Wilkinson's contributions further extend to the investigation of virulence factors in bacteria and the potential of protein lipidation in drug discovery for leishmaniasis.

Recent Grants

Grant: Close

A global network for neglected tropical diseases

Open Date: 2018-01-01

Close Date: 2021-12-01

Grant: Close

The Role of VapA in the pathogenesis of Rhodococcus equi

Open Date: 2017-12-01

Close Date: 2020-11-01

Grant: Close

TARGeTED: Tackling Antimicrobial Resistance through Goal-orientated Thinking in the EPS Disciplines

Open Date: 2015-04-30

Close Date: 2017-10-31

Grant: Close

Integrated multi-user crystallisation facility comprising a robot and storage system with image retrieval.

Open Date: 2013-12-01

Close Date: 2018-11-30

Grant: Close

Structure-function studies of the virulence associated proteins of Rhodococcus equi

Open Date: 2012-03-31

Close Date: 2015-03-30

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Rhodococcus equi is a Gram-positive facultative intracellular pathogen associated with life-threatening bronchopneumonial disease in foals. Key to R. equi’s intracellular survival in host macrophages is the production of virulence associated proteins (Vaps). Numerous vap genes are found on virulence plasmids isolated from different species, and the Vaps share a high degree of sequence identity. VapA has been extensively studied, and although vapK and vapN genes from other R. equi virulence plasmids have been shown to be essential for R. equi intracellular survival, their mode of action is less characterised. We, therefore, examined whether VapK and VapN worked mechanistically in the same way as VapA. Indeed, like VapA, VapK and VapN neutralised lysosomal pH and reduced lysosomal hydrolase activity. A loss of VapA and R. equi virulence could be regained by the presence of either VapK or VapN. The acid-neutralisation activity was also observed to a lesser extent with VapB. There was a differential activity across these virulence-promoting Vaps with the most “acid-neutralising” activity found with VapN, then VapA and K, and finally VapB. These data suggest that VapA production, which is often found in equine infections, can be substituted by VapK and B (produced by plasmids often found in porcine species) or VapN (produced by plasmids often isolated in bovine and human samples). These data imply that the molecular mechanism(s) that VapA uses to neutralise lysosomal acidity should also be seen in VapN and K which will help guide researchers in identifying their precise mode of action and aid the future development of targeted therapeutics.

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

James Ronald

University of York

UNITED KINGDOM
View details

Maggie Smith

Professor (Emeritus)

University of York

UNITED KINGDOM
View details

Marjan Van Der Woude

Professor

University of York

UNITED KINGDOM
View details

Michelle Rudden

Lecturer (Skin Microbiome)

University of Hull

UNITED KINGDOM
View details

Christoph George Baumann

Lecturer in Molecular Biophysics

University of York

UNITED KINGDOM
View details

Gavin Hugh Thomas

Professor

University of York

UNITED KINGDOM
View details

Paul R. Pryor

University of York

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.